Adamis pharmaceuticals says q3 revenue increased about 54% to $5.9 mln

Adamis pharmaceuticals announces third quarter 2019 financial results and business update.adamis pharmaceuticals corp - qtrly revenues increased approximately 54%, from $3.8 million to $5.9 million.adamis pharmaceuticals corp - cash and equivalents at end of q3 was approximately $12.1 million..

ADMP Ratings Summary

ADMP Quant Ranking